Safeguard Investment Advisory Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$243K	Buy	14,503 +640	+5%	+$10.7K	0.06%	120
2025 Q1	$213K	Buy	13,863 +4,352	+46%	+$66.9K	0.06%	128
2024 Q4	$210K	Buy	+9,511	New	+$210K	0.06%	106
2021 Q1	–	Sell	-4,388	Closed	-$42K	–	644
2020 Q4	$42K	Buy	+4,388	New	+$42K	0.04%	220